Contrast Injector Market (Product - Injector Systems, Consumables, and Accessories; Application - Radiology, Interventional Cardiology, Interventional Radiology, and Others): Global Industry Analysis, Trends, Market Size and Forecasts to 2024. The global contrast injector market is projected to grow at a CAGR of 7.1% over the forecast period of 2018-2024.

Pune, India -- (SBWire) -- 05/02/2019 --Our latest research report entitled Contrast Injector Market (by product type (injector systems, consumables, accessories), application (radiology, interventional cardiology, interventional radiology)) provides complete and deep insights into the market dynamics and growth of contrast injector. Latest information on market risks, industry chain structure contrast injector cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential contrast injector growth factors. The global contrast injector market is projected to grow at a CAGR of 7.1% over the forecast period of 2018-2024.

Make an Inquiry for Purchasing this Premium Report @ https://www.infiniumglobalresearch.com/reports/enquiry/1522

North America to Influence the Global Contrast Injector Market Through 2018-2024

Global contrast injector market was dominated by the North America region over the historic period of 2016. Factors which are driving the North American contrast injector market, are high adoption of contrast media injectors (CMI) in radiology procedures by hospitals and clinicians as compared to other regions, high prevalence of cardiovascular and neurological disorders. Additionally, a large number of people in these regions suffer from neurological and cardiovascular disorders, propelling the market for contrast media injectors in the region. In the coming years, the contrast media injector market would witness the highest growth rate in the Asia-Pacific region. The high growth of this market in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditures in APAC countries, rising aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.

Need Assistance? Send an Enquiry@ https://www.infiniumglobalresearch.com/reports/enquiry/1522

The increasing need for Contrast Scanning to Stimulate Demand for Contrast Media Injectors

Continuously, growing incidence of several life-threatening medical conditions, such as cardiac and neurological disorders, the rising incidence of cancer, hemorrhage, complex fractures, cardiovascular disorders, bone trauma and others are increasing the need for contrast scanning to identify the tissues that differ in physical density, leading to a surge in the demand for contrast media injectors in the near future.

CT Injectors are the Fastest Growing Segment

CT injectors are the fastest growing segment due to the large installed base of CT machines in health care centers, the low cost associated with scanning as compared to MRI and positron emission tomography (PET) along with greater patient compliance. MR injectors and angio/vascular injectors constitute other major instrument segments that provide high reliability and accuracy in contrast to injection.

Browse Detailed TOC, Description and Company Mentioned in this Premium Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-contrast-injector-market

Major Key Players mentioned in this Premium Report

The Leading companies in the market are Bayer AG (Medrad Inc.), Bracco Imaging S.P.A., Guerbet Group, Ulrich GmbH & Co. Kg., Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (SinoMDT), Apollo RT Co., Ltd., Vivid Imaging, Angiodynamics (Navilyst Medical, Inc) and GE Healthcare. These companies are looking forward to organic as well as non-organic growth opportunities. In addition, these are continuously focusing on improving productivity and efficiency of the company's performance, at the same time they are concentrating on their cost reduction to improve their profit margins.

Report Findings

1. Drivers

-High prevalence of cardiovascular and neurological disorders.

-A large number of approvals for contrast agents in different geographies.

-Growing demand for minimally invasive surgeries.

2. Restraints

-The high cost of Contrast Media Injectors.

3. Opportunities

-Ongoing advancement in Contrast Media Injectors.